We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
GigList is a platform that gives music fans a single place to find out about gigs happening in cities throughout the UK.  Using technology they source information from across the internet and bring it together in one place.
days to go: Expired investment: £69,788
BMM Networks is a company specialising in providing electric vehicle charging solutions throughout the UK. Currently, there are about 250,000 electric vehicles (EV) in the UK, with the hope that it will increase to 1 million by 2022. But this transition requires dependable and safe On-Street and Workplace charging stations. The UK Government, through the Office for Low Emission Vehicles (OLEV), has dedicated over £900 million of funding to expanding EV usage, of which £500 million is in scope for the BMM charging point business model. With the help of its delivery partner, BMM Energy Solutions Limited, BMM Networks has engaged with several local authorities to develop charging solutions. The company is one of the 10 approved framework providers for OLEV funded projects. Within this setup, OLEV will fund 75% of the installation cost or £5,000 for each charging point, leaving BMM to fund the balance of £1,250 per charger. This will enhance the coverage of charging points thereby boosting EV sales. The company is seeking £1.375 million of equity funding to boost its brand identity and business opportunities.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
Toraphene is an environmental technology company that aims to eliminate plastic waste. It has released with its product, Toraphene, to solve this crisis. It claims that Toraphene is a biodegradable, compostable and commercially-viable plastic packaging substitute for conventional plastic. The company asserts that its product is biodegradable even in the ocean, and has been developed using graphene technology. It is focussed on eliminating carrier bags and food containers in its first-round which account for 23% of marine waste. It aims to be a segment leader in the projected $25.4 billion biodegradable plastic industry by 2026. The company will use the investment to make Toraphene accessible to companies worldwide and make plastic packaging obsolete.

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,000,000
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £326,190
The Discovery Yachts Group was formed in 2017 in Southampton. It owns Discovery, Southerly, Bluewater and Britannia brands. Its mission is to create the finest luxury yacht destination. The brand has grown its order book 300% to £11m and is raising to expand its capacity, range and global reach.
days to go: Expired investment: £2,213,380
Solaris Photonics Ltd are developing the next generation of clean energy systems, multiplying the output of solar panels. The Solaris Photonics Multiplier is a power electronics device which can be retrofitted to solar panels to increase their power output by up to 4 times. The Alkaline Photovoltaic is a versatile photovoltaic cell, which can transform any surface into a solar panel.
days to go: Expired investment: £585,000
Ripple is a platform that facilitates co-ownership of renewable energy sources like wind farms and solar parks for both households and businesses. Their goal is to transform the energy industry by allowing consumers to easily and affordably co-own these assets, providing direct benefits in terms of cost savings and convenience.
days to go: Expired investment: £1,683,160
Pedals provide on-demand delivery by bicycle in London. Pedals London are currently in talks with a number of large companies that are looking to offer their customers a same-day delivery option. 
days to go: Expired investment: £138,310
Carbon Gold (CG) is an organic biochar producer and retailer. It claims that its products can replace harmful pesticides, last longer, and lock away CO2. The company's sales increased by 253% from £77,000 to £272,000 in 2020 with sales in 17 countries worldwide. CG's organic products employ biochar, a type of charcoal made from sustainably sourced materials. CG further enriches it with multiple strains of fungi, bacteria and minerals, that support healthy soil biology. The company is partnering with the Woodland Trust, is certified by the Soil Association, and is also a certified B Corp. The company will use the investment to boost its marketing, international development, and manufacturing.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £722,468
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph